Log In
Print this Print this

Compstatin (APL-1) (formerly POT-4)

  Manage Alerts
Collapse Summary General Information
Company Potentia Pharmaceuticals Inc.
DescriptionCompstatin-derived synthetic peptide complement 3 (C3) inhibitor Compstatin-derived synthetic peptide C3 inhibitor
Molecular Target Complement 3 (C3)
Mechanism of ActionComplement inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today